A risk we have to swallow: can we ever be sure that medicines are safe before they hit the market?

Robert Matthews*

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

With the increase in safety concerns, safety regulators and scientists are trying to determine the ways to uncover the truth regarding the safety of drugs which various companies are selling. Merck, the maker of Vioxx, a painkiller for arthritis sufferers, withdrew the medicine from market in September, 2004 after the drug was accused of increasing the risk of heart disease and stroke. It is almost impossible to be sure that a drug that appeared safe in trials will not cause ill effects when released onto the market. The problem with accepting the results of trials is that when it comes to detecting side effects most trials are too small to find anything less than decimation.

Original languageEnglish
JournalNew Scientist
Volume185
Issue number2489
Publication statusPublished - 5 Mar 2005

Fingerprint

Deglutition
Safety
Pharmaceutical Preparations
Arthritis
Heart Diseases
Stroke
Medicine

Cite this

@article{acb1a7ae7c2a4d5387d8b95548784a87,
title = "A risk we have to swallow: can we ever be sure that medicines are safe before they hit the market?",
abstract = "With the increase in safety concerns, safety regulators and scientists are trying to determine the ways to uncover the truth regarding the safety of drugs which various companies are selling. Merck, the maker of Vioxx, a painkiller for arthritis sufferers, withdrew the medicine from market in September, 2004 after the drug was accused of increasing the risk of heart disease and stroke. It is almost impossible to be sure that a drug that appeared safe in trials will not cause ill effects when released onto the market. The problem with accepting the results of trials is that when it comes to detecting side effects most trials are too small to find anything less than decimation.",
author = "Robert Matthews",
year = "2005",
month = "3",
day = "5",
language = "English",
volume = "185",
journal = "New Scientist",
issn = "0262-4079",
publisher = "Springer",
number = "2489",

}

A risk we have to swallow : can we ever be sure that medicines are safe before they hit the market? / Matthews, Robert.

In: New Scientist, Vol. 185, No. 2489, 05.03.2005.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A risk we have to swallow

T2 - can we ever be sure that medicines are safe before they hit the market?

AU - Matthews, Robert

PY - 2005/3/5

Y1 - 2005/3/5

N2 - With the increase in safety concerns, safety regulators and scientists are trying to determine the ways to uncover the truth regarding the safety of drugs which various companies are selling. Merck, the maker of Vioxx, a painkiller for arthritis sufferers, withdrew the medicine from market in September, 2004 after the drug was accused of increasing the risk of heart disease and stroke. It is almost impossible to be sure that a drug that appeared safe in trials will not cause ill effects when released onto the market. The problem with accepting the results of trials is that when it comes to detecting side effects most trials are too small to find anything less than decimation.

AB - With the increase in safety concerns, safety regulators and scientists are trying to determine the ways to uncover the truth regarding the safety of drugs which various companies are selling. Merck, the maker of Vioxx, a painkiller for arthritis sufferers, withdrew the medicine from market in September, 2004 after the drug was accused of increasing the risk of heart disease and stroke. It is almost impossible to be sure that a drug that appeared safe in trials will not cause ill effects when released onto the market. The problem with accepting the results of trials is that when it comes to detecting side effects most trials are too small to find anything less than decimation.

UR - http://www.scopus.com/inward/record.url?scp=14744281010&partnerID=8YFLogxK

M3 - Article

C2 - 15839012

AN - SCOPUS:14744281010

VL - 185

JO - New Scientist

JF - New Scientist

SN - 0262-4079

IS - 2489

ER -